Céline Charvin
Investment Director @ Demeter
Lyon, France
Céline Charvin is a seed investor at Demeter in Lyon focused on Biopharma and Health Care. Céline Charvin
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Céline Charvin invests in
Stages Céline Charvin invests in
Countries Céline Charvin invests in
Investment Focus
Industry
- Biopharma 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sirius NeoSight
|
Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it. | $4.6M / Seed / Feb 04, 2025 |
Co-Investors
About Demeter
Demeter is a major player in venture capital and private equity for the energy and ecological transition. They invest from 500 K€ to 30 M€ to support companies at all stages of their development: innovative startups, high growth SMEs and infrastructure projects.
Demeter Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Benjamin Lamothe
Investment Manager
|
|||
Bernard Maître
Venture Partner
|
|||
|
Céline Charvin
Investment Director
|
|||
Corinne Roussel
Chief Financial Officer
|
|||
Olivier Bordelanne
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Céline Charvin invest in?
Céline Charvin invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Céline Charvin last invest?
The most recent investment recorded for Céline Charvin closed in Feb 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
